These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. Silva PI, Daffre S, Bulet P. J Biol Chem; 2000 Oct 27; 275(43):33464-70. PubMed ID: 10942757 [Abstract] [Full Text] [Related]
26. RGD-Tachyplesin inhibits tumor growth. Chen Y, Xu X, Hong S, Chen J, Liu N, Underhill CB, Creswell K, Zhang L. Cancer Res; 2001 Mar 15; 61(6):2434-8. PubMed ID: 11289111 [Abstract] [Full Text] [Related]
28. Inhibitory effect of a lichen polysaccharide sulfate, GE-3-S, on the replication of human immunodeficiency virus (HIV) in vitro. Hirabayashi K, Iwata S, Ito M, Shigeta S, Narui T, Mori T, Shibata S. Chem Pharm Bull (Tokyo); 1989 Sep 15; 37(9):2410-2. PubMed ID: 2575016 [Abstract] [Full Text] [Related]
31. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. Yonezawa A, Kuwahara J, Fujii N, Sugiura Y. Biochemistry; 1992 Mar 24; 31(11):2998-3004. PubMed ID: 1372516 [Abstract] [Full Text] [Related]
33. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry. Hong J, Guan W, Jin G, Zhao H, Jiang X, Dai J. Microbiol Res; 2015 Jan 24; 170():69-77. PubMed ID: 25267486 [Abstract] [Full Text] [Related]
34. Action mechanism of tachyplesin I and effects of PEGylation. Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K. Biochim Biophys Acta; 2007 May 24; 1768(5):1160-9. PubMed ID: 17320042 [Abstract] [Full Text] [Related]
35. Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides. Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Balandin SV, Serebrovskaya EO, Belogurova-Ovchinnikova OY, Ovchinnikova TV. Chem Biol Drug Des; 2018 Jan 24; 91(1):294-303. PubMed ID: 28815904 [Abstract] [Full Text] [Related]
36. Effects of tachyplesin I on human U251 glioma stem cells. Ding H, Jin G, Zhang L, Dai J, Dang J, Han Y. Mol Med Rep; 2015 Apr 24; 11(4):2953-8. PubMed ID: 25434611 [Abstract] [Full Text] [Related]
37. Conformations and orientations of aromatic amino acid residues of tachyplesin I in phospholipid membranes. Oishi O, Yamashita S, Nishimoto E, Lee S, Sugihara G, Ohno M. Biochemistry; 1997 Apr 08; 36(14):4352-9. PubMed ID: 9100032 [Abstract] [Full Text] [Related]
38. In Vitro Activity of the Limulus Antimicrobial Peptide Tachyplesin I on Marine Bivalve Pathogens. Morvan A, Iwanaga S, Comps M, Bachere E. J Invertebr Pathol; 1997 Mar 08; 69(2):177-82. PubMed ID: 9056468 [Abstract] [Full Text] [Related]
39. Efflux of potassium ion is an important reason of HL-60 cells apoptosis induced by tachyplesin. Zhang HT, Wu J, Zhang HF, Zhu QF. Acta Pharmacol Sin; 2006 Oct 08; 27(10):1367-74. PubMed ID: 17007745 [Abstract] [Full Text] [Related]
40. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. Wachinger M, Kleinschmidt A, Winder D, von Pechmann N, Ludvigsen A, Neumann M, Holle R, Salmons B, Erfle V, Brack-Werner R. J Gen Virol; 1998 Apr 08; 79 ( Pt 4)():731-40. PubMed ID: 9568968 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]